{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:09:24Z","timestamp":1789362564595,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.035","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T17:30:35Z","timestamp":1486056635000},"page":"1293-1298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The rise and fall of pneumococcal serotypes carried in the PCV era"],"prefix":"10.1016","volume":"35","author":[{"given":"Vanessa T.","family":"Devine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.C.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Tuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"O'Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyasharmila","family":"Kuruparan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.035_b0005","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological report 2014 \u2013 vaccine preventable diseases \u2013 invasive bacterial disease <http:\/\/ecdc.europa.eu\/>."},{"key":"10.1016\/j.vaccine.2017.01.035_b0010","unstructured":"Centers for Disease Control and Prevention. 2014. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae; 2014."},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.035_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.inf.0000151030.10159.b1","article-title":"Acquisition of Streptococcus pneumoniae and nonspecific morbidity in infants and their families: a cohort study","volume":"24","author":"Sleeman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.035_b0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00006454-199310000-00006","article-title":"Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance","volume":"12","author":"Mastro","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.01.035_b0025","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/165-Supplement_1-S38","article-title":"Nasopharyngeal colonization during the first year of life","volume":"165","author":"Aniansson","year":"1992","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.035_b0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00006454-199906000-00008","article-title":"Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children","volume":"18","author":"Principi","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2017.01.035_b0035","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.035_b0040","unstructured":"Donaldson L, Beasley C, Howe J. Planned changes to the routine Childhood Immunisation Programme. Department of Health National Archives 2006; <http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/>, <http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Dearcolleagueletters\/DH_4128120>."},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.035_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11908-014-0403-3","article-title":"The relevance of pneumococcal serotypes","volume":"16","author":"Rodrigo","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2017.01.035_b0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.vaccine.2012.11.103","article-title":"Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002\u20132010","volume":"31","author":"Liesenborghs","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.035_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997\u20132007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.035_b0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.01.035_b0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/infdis\/jiu213","article-title":"Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England","volume":"210","author":"Moore","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.035_b0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.035_b0075","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.01.035_b0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.035_b0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"31","key":"10.1016\/j.vaccine.2017.01.035_b0090","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.vaccine.2013.04.075","article-title":"Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3\u2013year cross-sectional population based analysis","volume":"31","author":"Tocheva","year":"2013","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2017.01.035_b0095","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.035_b0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1101\/gr.074492.107","article-title":"Velvet: algorithms for de novo short read assembly using de Bruijn graphs","volume":"18","author":"Zerbino","year":"2008","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2017.01.035_b0105","author":"Victorian Bioinformatics Consortium"},{"issue":"26","key":"10.1016\/j.vaccine.2017.01.035_b0110","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1016\/j.vaccine.2011.04.004","article-title":"Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children","volume":"29","author":"Tocheva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.035_b0115","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ng.2625","article-title":"Population genomics of post-vaccine changes in pneumococcal epidemiology","volume":"45","author":"Croucher","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2017.01.035_b0120","unstructured":"Public Health England. Pneumococcal disease: cases caused by strains covered by Prevenar 13 vaccine. <http:\/\/www.gov.uk\/government\/publications\/pneumococcal-disease-cases-caused-by-strains-covered-by-prevenar-13-vaccine\/pneumococcal-disease-cases-caused-by-strains-covered-by-prevenar-13-vaccine>."},{"issue":"38","key":"10.1016\/j.vaccine.2017.01.035_b0125","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Sweden Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.01.035_b0130","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/INF.0000000000000849","article-title":"Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia","volume":"34","author":"Desai","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2017.01.035_b0135","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.035_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12879-015-0941-9","article-title":"Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era","volume":"15","author":"van der Linden","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.01.035_b0145","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/INF.0000000000000751","article-title":"Decreased carriage and genetic shifts in the Streptococcus pneumoniae population after changing the 7-valent to the 13-valent pneumococcal vaccine in Norway","volume":"34","author":"Steens","year":"2015","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:31:37Z","timestamp":1536067897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17300841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17300841"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rise and fall of pneumococcal serotypes carried in the PCV era","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}